Conference abstract · 21 Sep 2015
Conference abstractPublished 6 Oct 2015
Imaging targeted delivery using FRET
Albany Medical Center, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Traditional cancer therapy generally leads to harmful side effects, thus warranting development of targeted therapies, which are better tolerated by cancer patients. Our goal is to develop in vivo non-invasive optical imaging assays for optimization of anticancer drug targeted therapy. We have established a fluorescence lifetime FÃ?¶rster Resonance Energy Transfer (FL-FRET) non-invasive whole-body in vivo tomographic imaging technique that can discriminate bound and internalized near-infrared (NIR)-labeled transferrin (Tfn) from free, soluble NIR-Tfn. This FRET-based assay exploits the homodimeric nature of transferrin receptor (TFR) that binds two molecules of Tfn in close proximity to determine dimerization and internalization of TFR-Tfn complexes into cancer cells. The Tfn FRET assay has been validated in vitro by visible and NIRFRET microscopy. FL-FRET tomographic imaging in vivo has been used to measure the internalization of tail-vein injected NIR-Tfn into human breast T47D tumor xenografts in live nude mice. Quantification of FRET donor % (FD%) in T47D tumor xenografts in vivo, indicates a higher proportion of FD% with increasing acceptor:donor ratio, demonstrating tumor uptake of NIR-Tfn. Tfn uptake concentration curve shows high sensitivity of FL-FRET imaging using NIR-Tfn as low as 10Ã?¼g/ml of blood. Furthermore, relative high FD% for holo-Tfn (iron-loaded) compared to that of apo-Tfn (iron-depleted) demonstrates specific TFR-mediated uptake of holo-Tfn by T47D tumor xenografts, as expected since irondepleted apo-Tfn shows reduced binding affinity towards TFR. In conclusion, we have successfully demonstrated the quantitative receptor-mediated uptake of Tfn into human breast tumors in vivo using a novel non-invasive NIR FL-FRET tomographic imaging assay.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 4 Mar 2024
Bioorthogonal Click Chemistry for Imaging and Targeted Drug Delivery
Conference abstract · 7 Mar 2019
Plasmonic nanostructures for imaging and targeting drug delivery
Conference abstract · 29 Nov 2018
Electro-magnetically actuated targeted drug delivery approach using Imaging technology, PID feedback control and MATLAB
Conference abstract · 11 Sep 2018
Fluorescent and T1 MRI active Multilayer Nanoparticle for Imaging and Targeting Cellular Delivery
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Research article · 27 Jul 2026
Qualitative LC/MS Assessment of Fenfluramine Hydrochloride After Dilution in Purified Water : A Preliminary Study and Case Report
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Margarida Barroso”
